Labcorp Competitive Intelligence & Landscape

Labcorp (labcorp.com) is a global life sciences and healthcare company dedicated to improving health and lives through its extensive laboratory services [https://www.labcorp.com/about]. With a legacy spanning over 50 years, the company has evolved from a local lab into a leader in diagnostics and drug development [https://www.labcorp.com/about/our-story/history]. Its mission is to "improve health and improve lives" by providing answers that advance science and healthcare [https://labcorp.com/].

Labcorp offers a comprehensive suite of diagnostic and drug development laboratory capabilities [https://ir.labcorp.com/]. Key services include lab diagnostics, drug development, and various global life sciences solutions [https://labcorp.com/]. The company serves a diverse target market including individuals and patients who can shop for tests, view results, and pay bills; providers such as doctors and experts using test finders and portals; health systems and organizations including hospitals, health systems, and managed care providers; and biopharma & investigators for nonclinical research and central laboratory services [https://labcorp.com/].

With nearly 70,000 employees globally, Labcorp is led by Chairman, President, and CEO Adam Schechter, who assumed the CEO role in 2019 and became Chairman in May 2020 [https://careers.labcorp.com/global/en/home, https://ir.labcorp.com/corporate-governance/management]. The company maintains a significant physical presence with approximately 2,200 patient service centers and over 7,000 in-office phlebotomists across the United States [https://www.labcorp.com/about/corporate-facts].

Labcorp's extensive offerings include OnDemand Testing with at-home kits for various conditions, specialized testing for diseases and therapeutic areas like cancer, neurology, and rheumatology, and advanced scientific lab disciplines such as genetics and digital pathology [https://labcorp.com/]. They also provide services for industries including healthcare, pharma, crop & agricultural, chemical & environmental, and novel food safety testing [https://labcorp.com/]. The company's focus is on combining cutting-edge innovation, science, and technology to address significant healthcare challenges [https://careers.labcorp.com/global/en/home].

Labcorp (labcorp.com) offers various diagnostic and wellness testing services with different pricing structures depending on the service. For many services, Labcorp accepts a wide range of insurance plans, with over 700 health plans nationwide, and directly bills insurance companies [labcorp.com/patients]. Patients are responsible for co-pays and any charges not covered by their provider, but Labcorp also provides support programs for those in need and offers interest-free installment plans for balances of at least $50. General billing inquiries and payment plan setups can be handled by calling 800-845-6167 [labcorp.com/patients/billing][labcorp.com/node/22868034][labcorp.com/patients/help].

For those seeking direct purchases, Labcorp OnDemand allows individuals to buy health and wellness tests online without insurance billing [labcorp.com/patients/labcorp-ondemand]. This platform provides access to a variety of tests, including general health checks and specific areas like fertility, anemia, diabetes, and allergies. Pricing for Labcorp OnDemand tests varies: a Men's Health Test and Women's Health Test are both available for $219, while a Comprehensive Testosterone Test costs $159. A Quantitative hCG Pregnancy Test is priced at $49 [ondemand.labcorp.com/products][ondemand.labcorp.com/products/all-tests]. More extensive options like the Custom Men's Health Test are available for $651 [ondemand.labcorp.com/products/annual-wellness].

In addition to general wellness and specific health panels, Labcorp also provides DNA Paternity Tests through Labcorp DNA. Legal paternity tests start at $525, while at-home kits are available starting at $210. Other DNA services include Legal Immigration Testing, beginning at $550, Sibling Testing from $420, and Twin Testing [dna.labcorp.com/dna-testing]. For carrier screening panels and prenatal cfDNA (NIPT) screening, Labcorp offers a Cost Estimator, and inquiries can be made by calling 844-799-3243 [womenshealth.labcorp.com/patients/cost-estimator].

Labcorp (labcorp.com) maintains a robust and active hiring strategy, consistently seeking to expand its workforce across a diverse range of roles. The company's careers portal highlights a focus on attracting talent through various avenues, including dedicated programs for Students and Graduates and US Military and Veterans [careers.labcorp.com/global/en/home]. This commitment to talent acquisition suggests a steady growth trajectory for the global life sciences company.

Recent hiring trends at Labcorp indicate a strong emphasis on core operational and scientific roles. Notable job openings frequently include positions in Laboratory Operations, such as Anatomic Pathology Laboratory Supervisor, Blood Bank Lab Technologist (with sign-on bonuses up to $10,000), Clinical Lab Scientist - Molecular, and Clinical Lab Technician (including entry-level roles with training provided) [careers.labcorp.com/global/en/laboratory-operations]. Beyond the lab, Labcorp also actively recruits for Information Technology, Customer Support/Call Centers, Administrative Services, Business Development and Commercial, Couriers, and Human Resources [careers.labcorp.com/global/en/search-results]. The presence of roles like Warehouse Associate and Specimen Accessioner further demonstrates the breadth of their operational needs [careers.labcorp.com/global/en/job/COVAGLOBAL265230EXTERNALENGLOBAL/Warehouse-Associate, careers.labcorp.com/global/en/job/COVAGLOBAL265677EXTERNALENGLOBAL/Specimen-Accessioner].

Labcorp also embraces modern work arrangements, offering remote job opportunities and inviting candidates to join their Talent Network to receive updates on available positions [careers.labcorp.com/global/en/remote-jobs, careers.labcorp.com/global/en/c/information-technology-jobs]. The provision of sign-on bonuses for certain laboratory roles suggests a competitive landscape for skilled professionals and an aggressive approach to filling critical positions within their diagnostic and drug development segments. While specific layoff information is not highlighted on their careers pages, the consistent recruitment across various departments, from early career to specialized roles, signals a strategic focus on sustained organizational growth and the continuous enhancement of their service capabilities in the global healthcare and scientific industries.

Labcorp (labcorp.com), a global leader in innovative laboratory services, demonstrates robust financial performance with consistent revenue growth. For the full year 2025, the company reported a revenue of $13.95 billion, an increase from $13.01 billion in the previous year. Diluted EPS for the full year 2025 stood at $10.46, up from $8.84, while adjusted EPS reached $16.44, compared to $14.57 in 2024. The company's free cash flow for 2025 was $1.21 billion, an increase from $1.10 billion in 2024 [https://ir.labcorp.com/news-releases/news-release-details/labcorp-announces-2025-fourth-quarter-and-full-year-results].

Looking ahead, Labcorp has provided strong guidance for its future financial health. For the full year 2026, the company anticipates revenue to be between $14.61 billion and $14.79 billion, representing a midpoint growth of 5.4%. Adjusted EPS guidance for 2026 is projected to be in the range of $17.70 to $18.35 [https://ir.labcorp.com/news-releases/news-release-details/labcorp-announces-2026-first-quarter-results-raises-full-year]. Quarterly results further underscore this growth, with Q1 2026 revenue at $3.54 billion, up 5.8% from $3.35 billion in Q1 2025, and adjusted EPS at $4.25, an increase of 10.6% from $3.84 in the prior year [https://ir.labcorp.com/news-releases/news-release-details/labcorp-announces-2026-first-quarter-results-raises-full-year].

Labcorp maintains a transparent financial reporting structure, making its annual reports, proxy statements, and quarterly 10-Q and annual 10-K filings readily available to investors [https://ir.labcorp.com/financials/annual-reports]. In May 2024, the company completed a holding company reorganization, with Labcorp Holdings Inc. becoming the new public holding company.

Labcorp Holdings Inc. has no independent assets or operations and its sole ownership interest is in Laboratory Corporation of America Holdings (LCAH), which is organized into two segments: Diagnostics Laboratories (Dx) and Drug Development [https://ir.labcorp.com/static-files/8488f4b1-35f1-49bd-9fc0-0aaf0a744944]. The company, trading on the NYSE under the ticker LH, serves clients in approximately 100 countries [https://ir.labcorp.com/].

Labcorp (labcorp.com) actively participates in and hosts a variety of events, including upcoming conferences, webinars, and scientific meetings, to highlight its expertise in healthcare advancements. Their "Education, Events & Experts" and "Science" sections on labcorp.com serve as central hubs for information on these engagements, providing access to posters, publications, and details on upcoming activities.

Looking ahead, Labcorp plans to attend significant industry conferences. These include the 2026 ASCO® Annual Meeting, the Meeting of the Minds (also occurring in July 2026 at the ADLM Annual Scientific Meeting and Clinical Lab Expo in Anaheim, CA), and the ACMG Conference 2026 in Baltimore, MA, from March 10-14, where they will have a booth and present scientific posters and platforms. They will also be present at the Liquid Biopsy for Precision Oncology Summit 2026 from February 3-5, 2026, which will include a speaking engagement.

Beyond major conferences, Labcorp engages with the scientific and medical community through more specialized events. This includes the Biomarkers and Precision Medicine 2025 conference from September 30 to October 1, 2025, where they will host a pre-event half-day workshop. They are also slated to participate in the World CB & CDx from September 22-25, 2025, and SETAC Europe from May 11-15, 2025. These events underscore Labcorp's commitment to advancing precision medicine and delivering innovative therapies.

Labcorp also offers numerous webinars, both recent and upcoming, covering diverse topics such as an "Overview of Labcorp Universal Method Validation Standard Operating Procedures" and discussions on "Cytomegalovirus (CMV)." These webinars, alongside their conference participations, enable Labcorp to share scientific knowledge, educate professionals, and connect with individuals, patients, and healthcare organizations across the globe.